Urology Journal

Overview

publication venue for

• Co-Manifestations of Genital Neurofibromatosis in a Patient with Neurofibromatosis Type 1. 2020
• Concurrent Robotic Pyelolithotomy and Partial Nephrectomy: Tips and Tricks. 2018
• Precise Clamping of Renal Artery With Endovascular Stents During Robotic Partial Nephrectomy: Technical Hints to Optimize Outcomes. 2018
• Intraductal Carcinoma of the Prostate: A Risk for Rapid Recurrence. 2017
• A case of penetrating glass foreign body within the renal cortex. 2014
• A 60-year-old woman with an incidentally discovered right renal mass. 2012
• Symptomatic bilateral delayed partial ureteral obstruction after bilateral endoscopic correction of vesicoureteral reflux with dextranomer/hyaluronic acid polymer. 2012
• Primary carcinoid tumor of urinary bladder discovered on pelvic magnetic resonance imaging. 2012
• Müllerian remnant malignancy. 2012
• Incidental ureteral catheterization with cystometry catheter during video urodynamics: a prompt diagnosis. 2011
• Scrotal ulcer after intraperitoneal hyperthermic chemotherapy. 2007
• Synchronous unilateral renal cell carcinoma and Kimura disease of the kidney. 2006
• Violaceous exanthem as a manifestation of metastatic prostate cancer in skin. 2006
• Metastatic renal cell carcinoma to the nose and ethmoid sinus. 2006
• Neuromuscular complications after percutaneous radiofrequency ablation of renal tumors. 2005
• Page kidney as a complication of percutaneous antegrade endopyelotomy. 2005
• Small (less than 1.5 cm) renal tumor with confirmed lung metastases. 2005
• Renal angiomyolipoma with contrast-enhancing elements mimicking renal malignancy: radiographic and pathologic evaluation. 2004
• Distinguishing splenosis from renal masses using ferumoxide-enhanced magnetic resonance imaging. 2003
• Rare case of metastatic prostate adenocarcinoma to the pituitary. 2003
• Prostate adenocarcinoma presenting with inguinal lymphadenopathy. 2003
• Recurrence of prostate adenocarcinoma presenting with multiple myeloma simulating skeletal metastases of prostate adenocarcinoma. 2002
• Large granular cell tumor of the penis in a 53-year-old man with coexisting prostate cancer. 2002
• Magnetic resonance imaging in the evaluation of congenital anomalies of the external genitalia. 2001
• Undifferentiated sex cord/stromal testis tumor. 2000
• Renal cell carcinoma with an infrarenal vena caval tumor thrombus. 1999
• Polymerase chain reaction used to detect candidemia in patients with candiduria. 1998
• Laparoscopic surgery in children with ventriculoperitoneal shunts: effect of pneumoperitoneum on intracranial pressure--preliminary experience. 1997
• Testicular microlithiasis as a predictor of intratubular germ cell neoplasia. 1996
• Benign ectopic prostatic tissue involving the seminal vesicle in a patient with prostate cancer: recognition and implications for staging. 1996
• Balloon-wire retrieval of a migrated urethral stent in the early postoperative period. 1996
• Magnetic resonance imaging of vascular lesions of the scrotum and penis. 1995
• Staphylococcus periprostatic abscess: an unusual cause of acute urinary retention. 1995
• Postradical orchiectomy hemorrhage: should an alteration in staging strategy for testicular cancer be considered? 1995
• Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinoma. 1995
• An unusual cause of duodenal obstruction: ureteropelvic junction obstruction and the renoalimentary relationship. 1994
• Management and evaluation of localized amyloidosis of the bladder: two case reports. 1994
• Untreated hypernephroma of thirty-three years. 1993
• Sonographic monitoring of prostate cancer after definitive radiotherapy. 1992
• Chronic renal failure secondary to post-hysterectomy vaginal prolapse. 1991
• Perirenal lipoma versus renal cell carcinoma. 1991
• Kaposi sarcoma of penis and genitalia: a disease of our times. 1988
• Hemorrhage: a complication of metastatic testicular choriocarcinoma. 1987
• Preoperative assessment of retroperitoneal pathology by magnetic resonance imaging. Primary leiomyosarcoma of inferior vena cava. 1986
• Magnetic resonance imaging: its application to male infertility. 1986
• Treatment of malakoplakia of bladder with intravesical neosporin irrigation. 1986
• Ureteral stent in management of fungal pyonephrosis due to Torulopsis glabrata. 1984
• Congenital hemihypertrophy with adrenal carcinoma and medullary sponge kidney. 1983
• Psuedocrossed renal ectopia secondary to retroperitoneal liposarcoma. 1981
• Agranulocytosis associated with flucytosine for urinary candidiasis. 1976
• Infarction of testicle and Schistosoma mansoni. 1975
• Pseudocyst of pancreas simulating a renal neoplasm. 1975
• Determining a real-world definition of percutaneous tibial nerve stimulation induction therapy in Medicare beneficiaries with overactive bladder. 2026
• Urinary pH, Methenamine, and Formaldehyde Levels in the Management of Postmenopausal Women With Recurrent Urinary Tract Infections: A 1-Year Prospective Pilot Study With Extended Follow-up. 2026
• Clinician- and Geographic-level Variation in Utilization of Sacral Neuromodulation and OnabotulinumtoxinA Injections Among Medicare Beneficiaries With Overactive Bladder..  208. 2025
• Increasing Utilization of Sedation for Prostate Biopsies: National Trends, Predictors, and Patient Cost. 2025
• Utilization, Acute Complications, and Delays in Treatment Associated With Rectal Spacers for Prostate Cancer Radiotherapy. 2025
• Editorial Comment on "Association Between Social Determinants of Health and Choice of Urinary Reconstruction in Children". 2025
• Effect of Age on Robotic-Assisted Radical Prostatectomy Outcomes: A Multi-center Analysis..  202. 2025
• Management of Bladder Neck Contracture in a 73-Year-Old Male..  195. 2024
• The Yield of Genetic Testing in Management of Nephrolithiasis..  193. 2024
• Renal Autotransplantation: Association Between Preoperative Disease Duration and Surgical Outcomes..  192. 2024
• Time-Driven Activity-based Costing and Outcomes of Same-Day Discharge vs Inpatient Robotic Partial and Radical Nephrectomy..  188. 2024
• Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy..  188. 2024
• Pelvic Floor Disorders Among Minority Women: Differences in Prevalence, Severity and Health-Related Social Needs..  186. 2024
• Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive vs Software Fusion, A Multicenter Analysis..  186. 2024
• Long-term Outcomes With Macroplastique in Women With Stress Urinary Incontinence Secondary to Intrinsic Sphincter Deficiency..  185. 2024
• EDITORIAL COMMENT..  183. 2023
• A Cost Analysis of Phosphodiesterase Type 5 Inhibitors in the United States..  183. 2023
• The Impact of Obesity on Sperm Parameters in Young Adult Males: A Retrospective Study of Sperm Donors..  182. 2023
• AUTHOR REPLY..  179. 2023
• Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should we revisit the goals of care? 2023
• Adoption and Outcomes of Holmium Laser Enucleation of the Prostate in the United States..  179. 2023
• AUTHOR REPLY..  177. 2023
• The Effect of Bike Seat Models on Perineal Pressure During Cycling: Implications for Patients After Lower Genitourinary Reconstructive Surgery..  179. 2023
• Comparison of postoperative outcomes of TURP, laser vaporization and laser enucleation: A Double Propensity Score Matched Analysis. 2023
• The Revolving Door of Residency: Predictors of Residency Attrition for Urology Matriculants Between 2001 and 2016..  177. 2023
• Telehealth Sterilization Consultation Does Not Impact Likelihood of Vasectomy: A Retrospective Institutional Analysis..  176. 2023
• Current Practice Patterns in the Surgical Management of Benign Prostatic Hyperplasia..  175. 2023
• Prosteria - National Trends and Outcomes of More Frequent Than Guideline Recommended Prostate Specific Antigen Screening..  174. 2023
• Surgical Outcomes at a Single Institution of Infrapubic Insertion of Malleable Penile Prosthesis in Transmen..  173. 2023
• Implementation and Usability of an Electronic Medical Record-based Ureteral Stent Tracker..  173. 2022
• Trends in Antimicrobial Prophylaxis for Inflatable Penile Prosthesis Surgery from A Large National Cohort. 2022
• Effect of Surgeon and Facility Volume on Outcomes of Benign Prostatic Hyperplasia Surgery: Implications of Disparities in Access to Care at High-Volume Centers..  172. 2022
• Perioperative Nephrectomy Outcomes for Patients with Liver Disease: Implications for Liver Transplant Candidates. 2022
• Imaging After Ureteroscopy: Practice Patterns, Patient Adherence and Impact on Subsequent Management in an Urban Academic Hospital System..  171. 2022
• Financial Toxicity of Nephrolithiasis: The First Assessment of the Economic Stresses of Kidney Stone Treatment..  170. 2022
• Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation..  170. 2022
• Evaluating Surgical Outcomes of Robot Assisted Simple Prostatectomy in the Retreatment Setting..  170. 2022
• Predictors and Trends of Opioid-Sparing Radical Prostatectomy From a Large National Cohort..  168. 2022
• The Lack of a Physical Exam During New Patient Telehealth Visits Does Not Impact Plans for Office and Operating Room Procedures..  167. 2022
• Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case Series..  167. 2022
• Foley Catheter Balloon Rupture and Risk of Free Fragment Formation..  165. 2022
• Medical Malpractice Lawsuits Involving Urology Trainees..  166. 2022
• Standardized Letters of Recommendation and Success in the Urology Match..  166. 2022
• Longitudinal Changes in the Pelvic Pain Only and Widespread Pain Phenotypes Over One Year in the MAPP-I Urologic Chronic Pelvic Pain Syndrome (UCPPS) Cohort..  161. 2022
• Authorship Gender Composition in Urology Literature From 2015 Through 2020..  165. 2022
• Consumption of a Healthy Plant-based Diet is Associated With a Decreased Risk of Erectile Dysfunction: A Cross-sectional Study of the National Health and Nutrition Examination Survey..  161. 2022
• The Impact of Race and Sex on Metastatic Bladder Cancer Survival..  165. 2021
• A Legal Database Review of Circumcision Related Litigation in the United States..  160. 2021
• Development and Usability Testing of a Mobile Application to Monitor Patient-Reported Outcomes after Stress Urinary Incontinence Surgery..  159. 2021
• Characterizing Standardized Letters of Recommendation in Urology Residency Applications..  158. 2021
• Clinical Outcomes of Robotic Assisted Partial Nephrectomy for Pathologic T3a Renal Masses With Venous Tumor Thrombus..  159. 2021
• Institutional Opioid Prescription Guidelines are Effective in Reducing Post-Operative Prescriptions Following Urologic Surgery: Results From the American Urologic Association 2018 Census..  158. 2021
• Prostate Cancer Screening for Gay Men in the United States..  163. 2021
• Evaluating Quality Improvement and Patient Safety Amongst Practicing Urologists: Analysis of the 2018 American Urological Association Census..  156. 2021
• Impact of Plant-Based Diet on PSA Level: Data From the National Health and Nutrition Examination Survey..  156. 2021
• Comparative Effectiveness and Tolerability of Transperineal MRI-Targeted Prostate Biopsy under Local versus Sedation..  155. 2021
• Workers Died of Dyes: The Discovery of Occupational Bladder Cancers..  154. 2021
• Use of Pre-operative Pharmacologic Venous Thromboembolism Prophylaxis for Robotic Partial Nephrectomy..  154. 2021
• Playground Equipment-related Genital Injuries in Children: An Analysis of United States Emergency Departments Visits, 2010-2019..  152. 2021
• The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma..  154. 2021
• Epidemiology and Diagnosis of Erectile Dysfunction by Urologists Versus Non-Urologists in the United States: An Analysis of the National Ambulatory Medical Care Survey..  147. 2020
• Survival Outcomes in Neoadjuvant Chemotherapy for High-grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis..  146. 2020
• Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma..  146. 2020
• Variations in Perioperative Antibiotic Prescriptions Among Academic Urologists After Ambulatory Endoscopic Urologic Surgery: Impact on Infection Rates and Validation of 2019 Best Practice Statement..  146. 2020
• RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors..  144. 2020
• Ejaculatory Hood-Sparing Vaporization of the Prostate and Its Impact on Erectile, Ejaculatory, and Sexual Function..  144. 2020
• Transvaginal Paravaginal Native Tissue Anterior Repair Technique: Initial Outcomes..  150. 2020
• Outpatient Extraperitoneal Single-Port Robotic Radical Prostatectomy..  144. 2020
• Patient-Reported Quality of Life and Convalescence After Minimally Invasive Kidney Cancer Surgery..  144. 2020
• The Association Between 24-Hour Urine and Stone Recurrence Among High Risk Kidney Stone Formers: A Population Level Assessment..  144. 2020
• Gender Bias in Medicine: Does It Exist at AUA Plenary Sessions?.  150. 2020
• Use of a Risk Stratification Tool to Guide Evaluation of Patients With Asymptomatic Microscopic Hematuria..  141. 2020
• Single-Port Percutaneous Transvesical Simple Prostatectomy Using the SP Robotic System: Initial Clinical Experience..  141. 2020
• Single-Port Robotic Urological Surgery Using Purpose-Built Single-Port Surgical System: Single-Institutional Experience With the First 100 Cases..  140. 2020
• Treatment of Estrogen Levels in the Management of Hypogonadism: An Anonymous Survey of ISSM Members..  139. 2020
• Prostate Multiparametric Magnetic Resonance Imaging Features Following Partial Gland Cryoablation..  138. 2020
• Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States..  137. 2020
• Increased Risk of Hypogonadal Symptoms in Shift Workers With Shift Work Sleep Disorder..  138. 2020
• Risk Factors for Infection after Prostate Biopsy in the United States..  138. 2019
• Comparison of Urologic Transfers to Academic Medical Centers: A Multi-institutional Perspective..  136. 2019
• The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-Year Institutional Experience..  136. 2019
• A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy..  135. 2019
• Persistent Discordance in Grade, Stage, and NCCN Risk Stratification in Men Undergoing Targeted Biopsy and Radical Prostatectomy..  135. 2019
• Single Port Robotic Extra-peritoneal Dual Kidney Transplantation: Initial Preclinical Experience and Description of the Technique..  134. 2019
• Robot-assisted Laparoscopic Extravesical Cross-trigonal Ureteral Reimplantation With Tailoring for Primary Obstructive Megaureter..  134. 2019
• Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma..  134. 2019
• Regional Variation in Shock Wave Lithotripsy Utilization Among Medicare Patients with Nephrolithiasis..  133. 2019
• Intravesical Electromotive Botulinum Toxin Type A (Dysport) Administration in Children With Myelomeningocele..  132. 2019
• Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder Cancer..  131. 2019
• Overuse of Cystoscopic Surveillance Among Patients With Low-risk Non-Muscle-invasive Bladder Cancer - A National Study of Patient, Provider, and Facility Factors..  131. 2019
• Predicting the Impacted Ureteral Stone with Computed Tomography..  130. 2019
• Single-port Robotic Intracorporeal Ileal Conduit Urinary Diversion During Radical Cystectomy Using the SP Surgical System: Step-by-step Technique..  130. 2019
• Evaluating Clinical Outcomes of an Advanced Practice Provider-Led Newborn Circumcision Clinic..  127. 2019
• Perioperative Outcomes and Complications after Robotic Radical Cystectomy With Intracorporeal or Extracorporeal Ileal Conduit Urinary Diversion: Head-to-head Comparison From a Single-Institutional Prospective Study..  129. 2019
• Pure Single-Site Robot-Assisted Partial Nephrectomy Using the SP Surgical System: Initial Clinical Experience..  124. 2018
• Symptom Duration in Patients With Urologic Chronic Pelvic Pain Syndrome is not Associated With Pain Severity, Nonurologic Syndromes and Mental Health Symptoms: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Network Study..  124. 2018
• Single-Port Robot-Assisted Radical Prostatectomy: First Clinical Experience Using The SP Surgical System..  124. 2018
• An Infertile Couple's Long and Expensive Path to Varicocele Repair..  124. 2018
• Surgical Hints for Robot-Assisted Transvesical Simple Prostatectomy..  122. 2018
• Transperineal Approach for Intracorporeal Ileal Conduit Urinary Diversion Using a Purpose-built Single-port Robotic System: Step-by-step..  122. 2018
• Validation of a Simulation-training Model for Robotic Intracorporeal Bowel Anastomosis Using a Step-by-step Technique..  120. 2018
• Minimally Invasive Management of Ureteral Distal Strictures: Robotic Ureteroneocystostomy With a Bilateral Boari Flap..  120. 2018
• Robotic Partial Nephrectomy for Complex Hilar Tumors: Step by step..  120. 2018
• The Impact of Microsurgical Repair of Subclinical and Clinical Varicoceles on Total Motile Sperm Count: Is There a Difference?.  120. 2018
• Patient-specific Virtual Simulation-A State of the Art Approach to Teach Renal Tumor Localization..  120. 2018
• Infrared Light Structured Sensor Three-dimensional Approach to Estimate Kidney Volume: A Validation Study..  119. 2018
• Technique for Docking and Port Placement Using a Purpose-built Robotic System (SP1098) in Human Cadaver..  119. 2018
• Robotic Single-port Partial Prostatectomy for Anterior Tumors: Transvesical Approach..  118. 2018
• Hospital Charges and Length of Stay Following Radical Cystectomy in the Enhanced Recovery After Surgery Era..  111. 2017
• Development of a Natural Language Processing Engine to Generate Bladder Cancer Pathology Data for Health Services Research..  110. 2017
• The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study..  111. 2017
• The Burden of Cystoscopic Bladder Cancer Surveillance: Anxiety, Discomfort, and Patient Preferences for Decision Making..  108. 2017
• Scrotal Ultrasound for Pain: Low Frequency of Absolute Surgical Indications..  108. 2017
• Twitter Activity Associated With U.S. News and World Report Reputation Scores for Urology Departments..  108. 2017
• Ointment Fistulography: Introducing a Novel Technique for Single or Multiple Urethrocutaneous Fistula Diagnosis After Hypospadias Surgery..  106. 2017
• The First Filmed Prostatectomy, 1917: 100 Years of Movies in Urological Education..  105. 2017
• Robot-assisted Laparoscopic Resection of Renal Vein Leiomyosarcoma..  103. 2017
• A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer..  102. 2016
• Vasectomy Reversal Surgical Patterns: An Analysis of the American Board of Urology Case Logs..  107. 2016
• Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy..  103. 2016
• Outcomes and Prognostic Factors of Primary Urethral Cancer..  100. 2016
• Early Stage Bladder Cancer: Do Pathology Reports Tell Us What We Need to Know?.  98. 2016
• Main Renal Artery Clamping With or Without Renal Vein Clamping During Robotic Partial Nephrectomy for Clinical T1 Renal Masses: Perioperative and Long-term Functional Outcomes..  97. 2016
• The Evolving Management of Patients With Clinical Stage I Seminoma..  98. 2016
• Surgical Treatment of Tumors Involving Kidneys With Fusion Anomalies: A Contemporary Series..  98. 2016
• An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care..  96. 2016
• A Prospective Randomized Trial of the Effects of Early Enteral Feeding After Radical Cystectomy..  96. 2016
• International Medical Graduate Training in Urology: Are We Missing an Opportunity?.  95. 2016
• Impact of Ureteroscopy Before Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes..  94. 2016
• Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center Experience..  95. 2016
• Utilization of Preoperative Laboratory Testing for Low-risk, Ambulatory Urologic Procedures..  94. 2016
• Women in Urology Residency, 1978-2013: A Critical Look at Gender Representation in Our Specialty..  92. 2016
• Experienced Open vs Early Robotic-assisted Laparoscopic Radical Prostatectomy: A 10-year Prospective and Retrospective Comparison..  91. 2016
• Age, Body Mass Index, and Frequency of Sexual Activity are Independent Predictors of Testosterone Deficiency in Men With Erectile Dysfunction..  90. 2015
• Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1..  89. 2015
• Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer..  87. 2015
• The Correlation of Media Ranking's "Best" Hospitals and Surgical Outcomes Following Radical Cystectomy for Urothelial Cancer..  86. 2015
• New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors..  86. 2015
• Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical Tumors..  85. 2015
• Effect of Tadalafil Once Daily on Penile Length Loss and Morning Erections in Patients After Bilateral Nerve-sparing Radical Prostatectomy: Results From a Randomized Controlled Trial..  85. 2015
• Four flawed arguments against prostate-specific antigen screening (and 1 good one)..  85. 2015
• Joseph J. Kaufman: renaissance man..  85. 2015
• Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients..  85. 2015
• Decision analysis of dutasteride use for patients with negative prostate biopsy..  85. 2015
• Cost comparison of open and robotic partial nephrectomy using a short postoperative pathway..  85. 2015
• Evolution of laparoscopic donor nephrectomy technique and outcomes: a single-center experience with more than 1300 cases..  85. 2015
• Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form..  85. 2015
• Surgical competency for urethrovesical anastomosis during robot-assisted radical prostatectomy: development and validation of the robotic anastomosis competency evaluation..  85. 2015
• Split-cuff nipple technique of ureteral reimplantation in children with thick-walled bladders due to posterior urethral valves..  85. 2014
• The role of ultrasonography in predicting vesicoureteral reflux..  84. 2014
• Comparison of perioperative outcomes of retroperitoneal and transperitoneal minimally invasive partial nephrectomy after adjusting for tumor complexity..  84. 2014
• Who really benefits from nephron-sparing surgery?.  84. 2014
• Adult prostate sarcoma: the Memorial Sloan Kettering experience..  84. 2014
• Prostate size and adverse pathologic features in men undergoing radical prostatectomy..  84. 2014
• Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups..  84. 2014
• Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer..  83. 2014
• Counseling the post-radical prostatectomy patients about functional recovery: high predictiveness of current status..  84. 2014
• The impact of radical prostatectomy operative time on outcomes and costs..  83. 2014
• Clinicopathologic features of renomedullary interstitial cell tumor presenting as the main solid renal mass..  83. 2014
• Population-based comparative effectiveness of salvage radical prostatectomy vs cryotherapy..  83. 2014
• Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens..  83. 2014
• The role of magnetic resonance imaging in delineating clinically significant prostate cancer..  83. 2014
• Translabial ultrasonography for evaluation of synthetic mesh in the vagina..  83. 2013
• Midurethral sling is the dominant procedure for female stress urinary incontinence: analysis of case logs from certifying American Urologists..  82. 2013
• Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy..  82. 2013
• A retrospective review of office-based 532-nm GreenLight laser prostatectomy in men with symptomatic benign prostatic hyperplasia..  82. 2013
• Effect of visceral obesity on minimally invasive partial nephrectomy..  82. 2013
• Preventive effect of specific antioxidant on oxidative renal cell injury associated with renal crystal formation..  82. 2013
• Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes..  82. 2013
• Management of anastomotic stricture after artificial urinary sphincter placement in patients who underwent salvage prostatectomy..  82. 2013
• Factors associated with reduction in use of neoadjuvant androgen suppression therapy before radical prostatectomy..  81. 2013
• Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone..  81. 2013
• Assessing renal function after partial nephrectomy using renal nuclear scintigraphy and estimated glomerular filtration rate..  80. 2012
• Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers..  80. 2012
• Pubovesical fistula: a rare complication after treatment of prostate cancer..  80. 2012
• Higher RENAL Nephrometry Score is predictive of longer warm ischemia time and collecting system entry during laparoscopic and robotic-assisted partial nephrectomy..  79. 2012
• Role of isotope selection in long-term outcomes in patients with intermediate-risk prostate cancer treated with a combination of external beam radiotherapy and low-dose-rate interstitial brachytherapy..  79. 2012
• Intraoperative mannitol use does not improve long-term renal function outcomes after minimally invasive partial nephrectomy..  79. 2012
• Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site..  79. 2012
• Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer..  79. 2012
• Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder..  79. 2011
• We need a better marker for prostate cancer. How about renaming PSA?.  79. 2011
• Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissection..  79. 2011
• New data, new paradigms for treating prostate cancer patients--VI: novel hormonal therapy approaches..  78. 2011
• The use of tissue expanders for resurfacing of the penis for hypospadias cripples..  78. 2011
• Comparison of laparoendoscopic single-site donor nephrectomy and conventional laparoscopic donor nephrectomy: donor and recipient outcomes..  78. 2011
• The effects of acute and chronic psychological stress on bladder function in a rodent model..  78. 2011
• Models to predict positive prostate biopsies using the Tyrol screening study..  78. 2011
• Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis..  78. 2011
• Great meaningless questions in urology: which is better, open, laparoscopic, or robotic radical prostatectomy?.  77. 2011
• Simple, age-based formula for predicting renal length in children..  78. 2011
• Is right-sided laparoendoscopic single-site donor nephrectomy feasible?.  77. 2011
• Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update..  77. 2011
• Contemporary lymph node counts during primary retroperitoneal lymph node dissection..  77. 2010
• Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model..  77. 2010
• Ethnic variation in pelvimetric measures and its impact on positive surgical margins at radical prostatectomy..  76. 2010
• Her-2/neu expression in testicular cancer--a retrospective analysis in 57 cases..  76. 2010
• Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer..  76. 2010
• Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer..  77. 2010
• Misconceptions and miscommunication among aging women with overactive bladder symptoms..  77. 2010
• The role of preoperative endo-rectal coil magnetic resonance imaging in predicting surgical difficulty for robotic prostatectomy..  76. 2010
• Determinants of performing radical prostatectomy pelvic lymph node dissection and the number of lymph nodes removed in elderly men..  77. 2010
• Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy..  76. 2010
• Does prior abdominal surgery influence outcomes or complications of robotic-assisted laparoscopic radical prostatectomy?.  76. 2010
• A multicenter, double-blind, placebo-controlled trial to assess the efficacy of sildenafil citrate in men with unrecognized erectile dysfunction..  76. 2010
• Predictors of inguinal hernia after radical prostatectomy..  77. 2010
• Ureteroileal anastomosis with intraluminal visualization: technique and outcomes..  76. 2010
• ERG rearrangement metastasis patterns in locally advanced prostate cancer..  75. 2010
• Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s)..  76. 2010
• The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer..  75. 2010
• Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience..  75. 2010
• Economic costs of overactive bladder in the United States..  75. 2009
• Critical evaluation of perioperative complications in laparoscopic partial nephrectomy..  75. 2009
• Why can't nomograms be more like Netflix?.  75. 2009
• Thromboembolic complications of sling surgery for stress urinary incontinence among female Medicare beneficiaries..  74. 2009
• Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI..  75. 2009
• Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer..  76. 2009
• The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer..  75. 2009
• Trends in surgical management of stress urinary incontinence among female Medicare beneficiaries..  74. 2009
• Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 2..  73. 2009
• Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram..  73. 2009
• Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry..  73. 2009
• Antitumor effects of an imidazoquinoline in renal cell carcinoma..  73. 2009
• Evaluating localized prostate cancer and identifying candidates for focal therapy..  72. 2008
• Focal therapy for prostate cancer: analysis by an international panel..  72. 2008
• New treatments for localized prostate cancer..  72. 2008
• Prostate cancer: epidemiology and health-related quality of life..  72. 2008
• Direct comparison of surgical and functional outcomes of robotic-assisted versus pure laparoscopic radical prostatectomy: single-surgeon experience..  73. 2008
• Spiral sling salvage anti-incontinence surgery for women with refractory stress urinary incontinence: surgical outcome and satisfaction determined by patient-driven questionnaires..  72. 2008
• A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer..  72. 2008
• Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy..  72. 2008
• Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer..  72. 2008
• Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy..  72. 2008
• Analysis of the RNASEL/HPC1, and macrophage scavenger receptor 1 in Asian-Indian advanced prostate cancer..  72. 2008
• Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgery..  72. 2008
• Determinants of treatment regret in low-income, uninsured men with prostate cancer..  72. 2008
• Impotence and suing for sex in eighteenth-century England..  71. 2008
• Patient perceived outcomes of treatments used for interstitial cystitis..  71. 2008
• Prognostic significance of location of positive margins in radical prostatectomy specimens..  70. 2007
• Use of spinal anesthesia does not reduce intraoperative blood loss..  70. 2007
• Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer..  70. 2007
• Distinct patterns of endothelin axis expression in primary prostate cancer..  70. 2007
• Use of hydrophilic-coated urethral catheters in management of acute urinary retention..  70. 2007
• Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma..  69. 2007
• Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy..  69. 2007
• Tumor location does not affect long-term renal function after partial nephrectomy..  69. 2007
• Innovative single-armed suture technique for microsurgical vasoepididymostomy..  69. 2007
• Assessment of penile vibratory stimulation as a management strategy in men with secondary retarded orgasm..  69. 2007
• Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients..  69. 2007
• Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer..  69. 2007
• Microsurgical inguinal varicocelectomy with and without testicular delivery..  68. 2006
• Perioperative clinical thromboembolic events after radical or partial nephrectomy..  68. 2006
• Feasibility of laparoscopic approach in management of xanthogranulomatous pyelonephritis..  68. 2006
• Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression..  68. 2006
• Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention..  68. 2006
• Percutaneous renal cryoablation..  68. 2006
• Clinical sequelae of radiographic iceball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablation..  67. 2006
• The use of urine-based biomarkers in bladder cancer..  67. 2006
• True prevalence of urinary incontinence among female nursing home residents..  67. 2006
• Perineocele: symptom complex, description of anatomic defect, and surgical technique for repair..  67. 2006
• Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins?.  66. 2005
• Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients..  66. 2005
• Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome..  66. 2005
• Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta")..  66. 2005
• Transvaginal paravaginal repair of high-grade cystocele central and lateral defects with concomitant suburethral sling: report of early results, outcomes, and patient satisfaction with a new technique..  66. 2005
• Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL..  66. 2005
• Application of angiogenic factors for therapy of erectile dysfunction: protein and DNA transfer of VEGF 165 into the rat penis..  66. 2005
• Early patient self-assessed outcomes of nerve-sparing radical perineal prostatectomy..  66. 2005
• Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy..  66. 2005
• Effect of ureteral access sheath on stone-free rates in patients undergoing ureteroscopic management of renal calculi..  66. 2005
• Efficacy of continuous local anesthetic infusion for postoperative pain after radical retropubic prostatectomy..  66. 2005
• Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma..  66. 2005
• Supplement use among men with prostate cancer..  66. 2005
• Anterior vaginal wall surgery in elderly patients: outcomes and assessment..  65. 2005
• Structural and functional changes to the testis after conventional versus microdissection testicular sperm extraction..  65. 2005
• Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen..  65. 2005
• Comparison of nephron-sparing surgery in central versus peripheral renal tumors..  65. 2005
• Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers..  65. 2005
• Impact of vaginal surgery for stress urinary incontinence on female sexual function: is the use of polypropylene mesh detrimental?.  65. 2005
• High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates..  64. 2004
• Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables..  64. 2004
• Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer..  64. 2004
• Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer..  64. 2004
• Testosterone treatment of human foreskin in a novel transplant model..  63. 2004
• Evaluation of water jet morcellation as an alternative to hand morcellation of renal tissue ablation during laparoscopic nephrectomy: an in vitro study..  63. 2004
• Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease..  62 Suppl 1. 2003
• Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology..  62. 2003
• Dietary manipulation, ethnicity, and serum PSA levels..  62. 2003
• Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome..  62. 2003
• Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening..  62. 2003
• Discrepancy in patient and physician perception of patient's quality of life related to urinary symptoms..  62. 2003
• Long-term follow-up of bilateral sporadic renal tumors..  61. 2003
• Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results..  61. 2003
• Biochemical profile of stone-forming patients with diabetes mellitus..  61. 2003
• Cross-cultural validation of the UCLA prostate cancer index..  61. 2003
• Estimating survival benefit in castrate metastatic prostate cancer: decision making in proceeding to a definitive phase III trial..  61. 2003
• Hand-assisted laparoscopy for large renal specimens: a multi-institutional study..  61. 2003
• High expression of the Met receptor in prostate cancer metastasis to bone..  60. 2002
• Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia..  60. 2002
• Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome..  60. 2002
• Impact of a second transurethral resection on the staging of T1 bladder cancer..  60. 2002
• Blood loss during radical retropubic prostatectomy: relationship to morphologic features on preoperative endorectal magnetic resonance imaging..  59. 2002
• Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer..  59. 2002
• Natural history of chronic renal insufficiency after partial and radical nephrectomy..  59. 2002
• Early nasogastric tube removal combined with metoclopramide after postchemotherapy retroperitoneal lymph node dissection for metastatic testicular nonseminomatous germ cell tumor..  59. 2002
• Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression..  59. 2002
• Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up..  58. 2001
• Polypropylene sling for the treatment of stress urinary incontinence..  58. 2001
• Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin..  58. 2001
• Hand-assisted demucosalized gastrocystoplasty comparing different tissue closure methods..  58. 2001
• Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer..  58. 2001
• Nitric oxide synthase activity in human seminal plasma..  58. 2001
• Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma..  57. 2001
• Effect of local anesthetics on patient recovery after transrectal biopsy..  57. 2001
• Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology..  57. 2001
• Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up..  57. 2001
• Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen..  57. 2001
• Primary genitourinary melanoma..  57. 2001
• Histologic effects of testicular sperm extraction on the testicle in men with nonobstructive azoospermia..  57. 2001
• Interposition sural nerve grafting during radical retropubic prostatectomy..  57. 2001
• Second primary malignancies associated with renal cell carcinoma: influence of histologic type..  56. 2000
• Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging..  56. 2000
• Survey of neuromuscular injuries to the patient and surgeon during urologic laparoscopic surgery..  55. 2000
• Laser-assisted demucosalized gastrocystoplasty with autoaugmentation in a canine model..  55. 2000
• Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial..  55. 2000
• Magnetic resonance imaging and magnetic resonance angiography before postchemotherapy retroperitoneal lymph node dissection..  55. 2000
• Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial..  54. 1999
• Serum testosterone levels in African-American and white men undergoing prostate biopsy..  54. 1999
• Race is not an independent predictor of positive surgical margins after radical prostatectomy..  54. 1999
• Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL..  54. 1999
• Expression of vascular endothelial growth factor receptors in human prostate cancer..  54. 1999
• Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma..  54. 1999
• Endoscopic surgery and telemedicine in microgravity: developing contingency procedures for exploratory class spaceflight..  53. 1999
• Near-infrared confocal laser scanning microscopy of bladder tissue in vivo..  53. 1999
• Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer..  53. 1999
• Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer..  53. 1999
• Effect of methylene blue, indigo carmine, and Renografin on human sperm motility..  53. 1999
• Recall and attitudes in patients with prostate cancer..  53. 1999
• Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction..  52. 1998
• Increased incidence of depressive symptoms in men with erectile dysfunction..  52. 1998
• Testicular sperm extraction for nonobstructive azoospermia: results of a multibiopsy approach with optimized tissue dispersion..  52. 1998
• Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer..  52. 1998
• Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10..  52. 1998
• Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors..  52. 1998
• Impact of a clinical pathway for radical retropubic prostatectomy..  52. 1998
• Inconclusive clinical and ultrasound evaluation of the scrotum: impact of magnetic resonance imaging on patient management and cost..  51. 1998
• Human sperm NADH and NADPH diaphorase cytochemistry: correlation with sperm motility..  51. 1998
• Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells..  51. 1998
• Assessment of the feasibility and impact of shared decision making in prostate cancer..  51. 1998
• Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. The Multi Center Study Group..  50. 1997
• Improved detection of recurrent bladder cancer using the Bard BTA stat Test..  50. 1997
• Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer..  50. 1997
• Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma..  50. 1997
• Assessment of endpoints for clinical trials for localized prostate cancer..  49. 1997
• Assessment of hormone refractory prostate cancer..  49. 1997
• Planning controlled clinical trials. Prostatic cancer..  49. 1997
• Clinical significance of repeat sextant biopsies in prostate cancer patients..  49. 1997
• Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancers..  49. 1997
• Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia..  49. 1997
• The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results..  49. 1997
• Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy..  48. 1996
• Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies..  48. 1996
• Acid phosphatase: defining a role in androgen-independent prostate cancer..  47. 1996
• Surgical resection of brain metastases from renal cell carcinoma in 50 patients..  47. 1996
• Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation..  46. 1995
• Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?.  46. 1995
• Micropuncture retrieval of epididymal sperm with in vitro fertilization: importance of in vitro micromanipulation techniques..  46. 1995
• Laparoscopic laser-assisted bladder autoaugmentation..  46. 1995
• Use of a catheter limiter during intermittent catheterization..  45. 1995
• Distinguishing prognostic and treatment-predictive information for localized prostate cancer..  45. 1995
• Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy..  45. 1995
• Laser tissue welding in genitourinary reconstructive surgery: assessment of optimal suture materials..  45. 1995
• Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin..  44. 1994
• Telerobotic assisted laparoscopic surgery: initial laboratory and clinical experience..  44. 1994
• Xanthogranulomatous pyelonephritis: clinical findings and surgical considerations..  43. 1994
• Heterogeneity of prostate cancer in radical prostatectomy specimens..  43. 1994
• Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy..  43. 1994
• Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination..  42. 1993
• CO2 laser welding versus conventional microsuture repair in patch-graft urethroplasty..  41. 1993
• Surgical management of urethral strictures based on etiology. Where do urethral stents fit in?.  40. 1992
• Detection of residual prostate cancer after radiotherapy by sonographically guided needle biopsy..  39. 1992
• Initial results with slightly modified Kock pouch..  37. 1991
• Management of penile gunshot wounds..  36. 1990
• Sonographic measurements of transition zone of prostate in men with and without benign prostatic hyperplasia..  36. 1990
• Transrectal sonography for serial evaluation of prostatic malignancy..  36. 1990
• Ureteral stent for nonrefluxing, continent urinary diversions. Reduces complications and hospitalization for patients..  35. 1990
• Method of circumferential pressure dressing of scrotum following bilateral orchiectomy..  33. 1989
• Thomas Hillier and percutaneous nephrostomy..  33. 1989
• Assessment of male infertility: correlation between results of semen analysis and phosphorus-31 magnetic resonance spectroscopy..  33. 1989
• Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial..  32. 1988
• Cost-effectiveness of extracorporeal shock-wave lithotripsy..  31. 1988
• Octoson imaging in pediatric urology..  30. 1987
• Sonography in evaluation of carcinoma of bladder..  29. 1987
• Use of occlusion balloon catheter in percutaneous renal stone extraction..  27. 1986
• Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study..  25. 1985
• Prostatic biopsy after irradiation therapy for prostatic cancer..  25. 1985
• Renal carbuncle: comparison between surgical open drainage and closed percutaneous drainage..  25. 1985
• Magnetic resonance imaging and its application in urology..  23. 1984
• Penile corporoplasty with polytetrafluoroethylene (PTFE) grafts..  22. 1983
• Impact of symptomatic interval on prognosis of patients with stage III testicular cancer..  21. 1983
• Bivalve endoscopic sheath for direct vision insertion of urethral catheter..  16. 1980
• Recent advances in immunobiology of genitourinary cancer..  9. 1977
• Sigmoid conduit urinary diversion..  6. 1975
• Renal function after ligation of right renal vein..  5. 1975
• Scrotal aspiration: aid in early differentiation between torsion of spermatic cord and acute epididymo-orchitis..  4. 1974
• Flucytosine in urinary candida infections..  3. 1974
• Lipogranulomatosis of external genitalia..  3. 1974
• Serum finding associated with carcinoma of kidney..  2. 1973
• Penile tuberculosis..  1. 1973
• EDITORIAL COMMENT..  154. 2021
• AUTHOR REPLY..  144. 2020
• Editorial Comment..  126. 2019
• EDITORIAL COMMENT..  124. 2019
• Author Reply..  108. 2017
• Editorial Comment..  102. 2016
• Editorial Comment..  102. 2016
• Editorial Comment..  99. 2016
• Editorial comment..  85. 2015
• Editorial comment..  83. 2014
• Editorial comment..  83. 2014
• Editorial comment. A new diagnosis of a small kidney tumor..  73. 2009
• Editorial comment..  73. 2009
• Clinical states in prostate cancer: toward a dynamic model of disease progression..  55. 2000
• Assisted reproduction cost-effectiveness analysis..  50. 1997
• Non-Hodgkin's lymphoma can mimic renal adenocarcinoma with inferior vena caval involvement..  43. 1994
• Semen quality and chronic abacterial prostatitis..  39. 1992
• Editorial Comment on "Correlation of Prostate High-Resolution Micro-ultrasound With Multiparametric Magnetic Resonance Imaging". 2025
• Author Reply. 2022
• AUTHOR REPLY. 2020
• AUTHOR REPLY. 2020
• AUTHOR REPLY. 2020
• EDITORIAL COMMENT. 2020
• AUTHOR REPLY. 2020
• AUTHOR REPLY. 2020
• AUTHOR REPLY. 2019
• EDITORIAL COMMENT. 2019
• Author Reply. 2017
• Editorial Comment. 2016
• Implementation of Dynamically Updated Prediction Models at the Point of Care at a Major Cancer Center: Making Nomograms More Like Netflix. 2016
• Author Reply. 2016
• Reply: To PMID 26142590. 2015
• Reply: To PMID 25623680. 2015
• Reply: To PMID 24094653. 2013
• Editorial comment. 2013
• Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 1. 2009
• Reply to Letter to the Editor on "Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy". 2024
• Reply to Editorial Comments on "Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy". 2024
• Reply to Editorial Comment on "Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive vs Software Fusion, A Multicenter Analysis". 2024
• Re: Selective Serotonin Reuptake Inhibitor (SSRI) Use Is Not Associated With Impaired Semen Parameters. 2023
• Re: Dudith Pierre-Victor, Howard L. Parnes, Gerald L. Andriole, et al. Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening. Urology 2021 Jun 26;S0090-4295(21)00539-2. 2021
• AUTHOR REPLY. 2020
• Pelvic Hematoma following Urolift Procedure for BPH. 2019
• A Thoughtful Pause for Sparing Oophorectomy. 2019
• Re: Yadav et al: Single-stage Female Epispadias Repair by Combined Infrasymphyseal Bladder Neck Plication and Urethrogenitoplasty: A Novel Technique (Urology 2017;100:240-245). 2017
• Author Reply. 2016
• Reply to Re: The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. 2016
• Author Reply. 2016
• Reply to Letter to the Editor: Effect of Tadalafil Once Daily (OaD) on Penile Length Loss and Morning Erections in Patients Post Bilateral Nerve-sparing Radical Prostatectomy (nsRP): Results From a Randomized Controlled Trial (Urology 2015;85:1090-1096). 2015
• Reply by the authors. 2014
• Best practice policy statement on urologic surgery antimicrobial prophylaxis. 2009
• Correlation of radiation dose and impotence risk after three-dimensional conformal radiotherapy for prostate cancer. 2001
• Prostatitis: myths and realities. 1999
• Use of miconazole as bladder irrigant. 1984
• Editorial comment..  84. 2014
• Editorial comment..  84. 2014
• Reply: To PMID 24824406..  84. 2014
• Reply: To PMID 24768012..  83. 2014
• Editorial comment..  82. 2013
• Editorial comment..  81. 2013
• Editorial comment..  80. 2012
• Editorial comment..  78. 2011
• Editorial comment..  78. 2011
• Editorial comment..  78. 2011
• Editorial comment..  78. 2011
• Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder..  77. 2011
• Editorial comment. Tumor grade at margins of resection in radical prostatectomy specimens is an independent predictor of prognosis..  76. 2010
• Editorial comment..  75. 2010
• Editorial comment. Variations in International Prostate Symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer..  74. 2009
• Renal cryoablation: study with care--proceed with caution..  65. 2005
• Fresh testicular sperm from men with nonobstructive azoospermia works best for ICSI..  64. 2004
• Rationale for and results of nerve grafting during radical prostatectomy..  57. 2001
• Percent free prostate-specific antigen for first-time prostate biopsy..  57. 2001
• Use of Botulinum Toxin A (BoNT-A) in Detrusor External Sphincter Dyssynergia (DESD): A Systematic Review and Meta-analysis. 2020
• A review of contemporary data on surgically resected renal masses--benign or malignant? 2013
• Nonseminomatous germ cell tumors of the testis: current concepts and controversies. 1994
• Impact of GLP-1 Receptor Agonists on Male Fertility: Emerging Evidence and Future Directions. 2025
• Correlation not Causation - Looking Back at the History of VUR. 2024
• Trends in Presentation and Management of Pediatric Renal Trauma. 2023
• Real-World Complications of the SpaceOAR Hydrogel Spacer: A Review of the Manufacturer and User Facility Device Experience Database. 2023
• Evaluating the Learning Curve for In-office Freehand Cognitive Fusion Transperineal Prostate Biopsy. 2023
• A Comparison of Microwave Ablation and Cryoablation for the Treatment of Renal Cell Carcinoma: A Systematic Literature Review and Meta-analysis. 2023
• Radiation-induced Fistulas in Patients With Prior Pelvic Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis. 2023
• Long vs Short Acting Testosterone Treatments: A Look at the Risks. 2022
• Future of Male Infertility Evaluation and Treatment: Brief Review of Emerging Technology. 2022
• Perioperative Outcomes Between Single-Port and "Multi-Port" Robotic Assisted Radical Prostatectomy: Where do we stand? 2021
• Robotic One Access Surgery (R-1): Initial Preclinical Experience for Urological Surgeries. 2019
• Healthcare Costs of Post-Prostate Biopsy Sepsis. 2019
• Histologic Inflammatory Response to Transvaginal Polypropylene Mesh: A Systematic Review. 2017
• The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II). 2017
• Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review? 2016
• Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology. 2015
• A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. 2014
• Everything you always wanted to know about evaluating prediction models (but were too afraid to ask). 2010
• Complications associated with patient positioning in urologic surgery. 2010
• Standards for surgical complication reporting in urologic oncology: time for a change. 2007
• Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction. 2006
• Efficacy of periprostatic local anesthetic for prostate biopsy analgesia: a meta-analysis. 2006
• Chemoprevention of bladder cancer. 2006
• DNA-based molecular cytology for bladder cancer surveillance. 2006
• The diagnosis and staging of bladder cancer: from RBCs to TURs. 2006
• The management of superficial transitional cell carcinoma of the bladder. 2006
• The pathology of bladder cancer. 2006
• Therapy of invasive bladder cancer. 2006
• Urothelial cancer biomarkers for detection and surveillance. 2006
• Ureteroscopic management of renal calculi in anomalous kidneys. 2005
• Novel approaches to treat asymptomatic, hormone-naive patients with rising prostate-specific antigen after primary treatment for prostate cancer. 2003
• Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma. 2003
• Urologic aspects of andropause. 2003
• Gene therapy for prostate cancer. 2001
• Prostate-specific membrane antigen: present and future applications. 2000
• Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy. 1997
• Computer modeling in urology. 1996
• Hemospermia: diagnosis and management. 1995
• Laser tissue welding in urologic surgery. 1994
• Transrectal ultrasound in management of prostate cancer. 1989
• The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. 2016

Identity

ISO Abbreviation

• Urology

Linking ISSN

• 0090-4295

International Standard Serial Number (ISSN)

• 0090-4295

Electronic International Standard Serial Number (EISSN)

• 1527-9995